What we do
Services and Capabilities
From epigenetic testing strategy to actuarial consulting,
we bring the full stack of longevity intelligence to your organization.
🧬
Epigenetic Testing Strategy
We help organizations integrate epigenetic testing into their products and operations — from test selection to deployment, interpretation, and customer communication.
- Biological age testing program design
- Test selection and evaluation
- Customer-facing interpretation frameworks
- Longitudinal monitoring strategy
📊
Actuarial Consulting
We partner with actuarial leadership to develop proactive strategies that anticipate — and price for — life-extending technologies before they reshape mortality tables.
- Longevity risk assessment and modeling
- Technology-adjusted mortality forecasting
- Scenario planning for rapid lifespan expansion
- Population-specific impact analysis
🤖
AI & Data Science
Our team brings deep expertise applying machine learning to genetic, epigenetic, and health data — extracting insights that conventional analytics cannot.
- ML models for epigenetic biomarker analysis
- Predictive health risk scoring
- Behavioral pattern identification from sensor data
- Population health stratification
🌍
Life Expectancy Forecasting
We provide population-specific, technology-adjusted forecasts so organizations can plan pension systems, healthcare budgets, and product strategies with confidence.
- Global and regional life expectancy projections
- Segment-level mortality modeling
- Healthcare cost impact forecasting
- Scenario analysis for emerging technologies
Research findings
What our research has revealed
10+ Year
Additional lifespan possible within 20 years
Global life expectancy could easily expand by more than a decade as new technologies mature and reach population scale.
Now
Today's technologies extend life expectancy
Epigenetic testing, mRNA therapies, AI-driven health monitoring — the tools to improve longevity are already deployable.
↕
Significant variation across population
Technology impacts on life expectancy and healthcare costs vary dramatically across demographics. Averages mislead; segment-level analysis is essential.
Let's discuss your longevity strategy
We work with insurers, healthcare companies, governments, and longevity technology firms worldwide.